HT
NVCR icon

Headlands Technologies’s NovoCure NVCR Stock Holding History

Headlands Technologies’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-23,700
Closed -$306K – 893
2025
Q4 		$306K Sell
23,700
-29,167
-55% -$374K 0.03% 514
2025
Q3 		$683K Buy
52,867
+47,944
+974% +$641K 0.05% 296
2025
Q2 		$87.6K Buy
+4,923
New +$85.8K 0.01% 659
2024
Q2 		– Sell
-8,589
Closed -$134K – 1468
2024
Q1 		$134K Buy
+8,589
New +$126K 0.03% 472

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
QCM
Quantinno Capital Management New York $83.3B AUM 37.97% 1-Year Est. Return

Headlands Technologies's NVCR Position: Q1 2026 in Review

Headlands Technologies sold out of NovoCure (NVCR) in Q1 2026, closing a stake of 23,700 shares — an estimated $306K sold.

Headlands Technologies first reported a position in NVCR in Q1 2024 and held it in 4 quarters. The position peaked at $683K in Q3 2025. 223 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • Headlands Technologies reported no remaining NovoCure position as of Q1 2026 after selling out during the quarter.
  • Headlands Technologies sold 23,700 NovoCure shares in Q1 2026, an estimated $306K.
  • Headlands Technologies first reported a position in NovoCure in Q1 2024 and held it in 4 quarters.
  • Headlands Technologies's NovoCure position peaked at $683K in Q3 2025.
  • 223 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on Headlands Technologies's 13F filing for Q1 2026, filed 13 May 2026.